Understanding the New Genetics of Responsiveness to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

Understanding the New Genetics of Responsiveness to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Published:2007-02-01 Issue:2 Volume:12 Page:211-220
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Toschi Luca¹,Cappuzzo Federico¹

Affiliation:

1. Department of Hematology-Oncology, Istituto Clinico Humanitas, Rozzano, Italy

Abstract

Learning Objectives After completing this course, the reader will be able to: Select a patient candidate for a tyrosine kinase inhibitor therapy.Describe the mechanism of action of gefitinib and erlotinib.Discuss the role of clinical and biological factors as determinants for sensitivity or resistance to tyrosine kinase inhibitors in lung cancer. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-2-211

Reference92 articles.

1. Epidermal growth factor-related peptides and their receptors in human malignancies;Salomon;Crit Rev Oncol Hematol,1995

2. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia;Arteaga;Semin Oncol,2002

3. The epidermal growth factor receptor and its inhibition in cancer therapy;Woodburn;Pharmacol Ther,1999

4. The EGF receptor family as targets for cancer therapy;Mendelsohn;Oncogene,2000

5. Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer;Bunn PA;Semin Oncol,2002

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Angiogenesis in Non-small Cell Lung Cancer Tumor Behavior;Biochemical Basis and Therapeutic Implications of Angiogenesis;2017

2. Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2015-06

3. Molecular Profiling in Non–Small Cell Lung Cancer: A Step Toward Personalized Medicine;Archives of Pathology & Laboratory Medicine;2013-04-01

4. The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment;BioMed Research International;2013

5. Nonsmall Cell Lung Cancer Therapy: Insight into Multitargeted Small-Molecule Growth Factor Receptor Inhibitors;BioMed Research International;2013